WallStSmart
OABI

OmniAb Inc.

NASDAQ: OABI · HEALTHCARE · BIOTECHNOLOGY

$1.36
-2.86% today

Updated 2026-04-29

Market cap
$208.49M
P/E ratio
P/S ratio
11.17x
EPS (TTM)
$-0.57
Dividend yield
52W range
$1 – $2
Volume
0.4M

OmniAb Inc. (OABI) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
1 of 8
Last 8 quarters
Avg EPS surprise
-12.7%
Last 4 quarters
Revenue YoY growth
-22.5%
Most recent quarter
EPS YoY growth
+8.3%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+0.4%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
+4.4%
2026-03-05
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-05$-0.11-25.7%$1.81$1.89+4.4%
2025-11-04$-0.14-7.7%$1.48$1.43-3.7%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.09$-0.11-25.7%$8.38M-22.5%
2025-09-30$-0.13$-0.14-7.7%$2.24M-46.3%
2025-06-30$-0.13$-0.15-15.4%$3.90M-48.8%
2025-03-31$-0.17$-0.17-2.0%$4.15M+9.3%
2024-12-31$-0.10$-0.12-24.1%$10.80M+124.1%
2024-09-30$-0.14$-0.16-14.3%$4.17M-23.8%
2024-06-30$-0.17$-0.13+23.5%$7.61M+9.6%
2024-03-31$-0.16$-0.19-18.8%$3.80M-77.5%
2023-12-31$-0.15$-0.14+6.7%$4.82M
2023-09-30$-0.14$-0.16-14.3%$5.48M
2023-06-30$-0.12$-0.15-25.0%$6.95M
2023-03-31$-0.03$-0.08-166.7%$16.92M

Frequently asked questions

Has OmniAb Inc. beaten earnings estimates?
OmniAb Inc. has beaten Wall Street EPS estimates in 1 of its last 8 quarterly reports, with an average EPS surprise of -12.7% over the last 4 quarters.
How does OABI stock react to earnings?
OABI stock has moved an average of +0.4% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is OmniAb Inc.'s revenue growth rate?
OmniAb Inc. reported year-over-year revenue growth of -22.5% in its most recent quarter, with EPS growing +8.3% year-over-year.